120 related articles for article (PubMed ID: 22586172)
1. Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: data from 242 cases included in the CryoVas survey.
Terrier B; Carrat F; Krastinova E; Marie I; Launay D; Lacraz A; Belenotti P; de Saint Martin L; Quemeneur T; Huart A; Bonnet F; Le Guenno G; Kahn JE; Hinschberger O; Rullier P; Hummel A; Diot E; Pagnoux C; Lzaro E; Bridoux F; Zenone T; Hermine O; Leger JM; Mariette X; Senet P; Plaisier E; Cacoub P
Ann Rheum Dis; 2013 Mar; 72(3):374-80. PubMed ID: 22586172
[TBL] [Abstract][Full Text] [Related]
2. Presentation and prognosis of cardiac involvement in hepatitis C virus-related vasculitis.
Terrier B; Karras A; Cluzel P; Collet JP; Sène D; Saadoun D; Cacoub P
Am J Cardiol; 2013 Jan; 111(2):265-72. PubMed ID: 23116612
[TBL] [Abstract][Full Text] [Related]
3. Cryoglobulinemia vasculitis: an update.
Terrier B; Cacoub P
Curr Opin Rheumatol; 2013 Jan; 25(1):10-8. PubMed ID: 23196322
[TBL] [Abstract][Full Text] [Related]
4. Cryoglobulinemia Vasculitis.
Cacoub P; Comarmond C; Domont F; Savey L; Saadoun D
Am J Med; 2015 Sep; 128(9):950-5. PubMed ID: 25837517
[TBL] [Abstract][Full Text] [Related]
5. Non HCV-related infectious cryoglobulinemia vasculitis: Results from the French nationwide CryoVas survey and systematic review of the literature.
Terrier B; Marie I; Lacraz A; Belenotti P; Bonnet F; Chiche L; Graffin B; Hot A; Kahn JE; Michel C; Quemeneur T; de Saint-Martin L; Hermine O; Léger JM; Mariette X; Senet P; Plaisier E; Cacoub P
J Autoimmun; 2015 Dec; 65():74-81. PubMed ID: 26320984
[TBL] [Abstract][Full Text] [Related]
6. Mortality rate and outcome factors in mixed cryoglobulinaemia: the impact of hepatitis C virus.
Della Rossa A; Tavoni A; D'Ascanio A; Catarsi E; Marchi F; Bencivelli W; Salvadori S; Migliorini P; Bombardieri S
Scand J Rheumatol; 2010 Mar; 39(2):167-70. PubMed ID: 20337547
[TBL] [Abstract][Full Text] [Related]
7. Expert opinion on managing chronic HCV in patients with mixed cryoglobulinaemia vasculitis.
Zignego AL; Pawlotsky JM; Bondin M; Cacoub P
Antivir Ther; 2018; 23(Suppl 2):1-9. PubMed ID: 30451151
[TBL] [Abstract][Full Text] [Related]
8. Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia.
Saadoun D; Sellam J; Ghillani-Dalbin P; Crecel R; Piette JC; Cacoub P
Arch Intern Med; 2006 Oct; 166(19):2101-8. PubMed ID: 17060540
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and cost of hepatitis C virus cryoglobulinaemia vasculitis treatment: From interferon-based to direct-acting antivirals era.
Cacoub P; Vautier M; Desbois AC; Lafuma A; Saadoun D
Liver Int; 2017 Dec; 37(12):1805-1813. PubMed ID: 28467688
[TBL] [Abstract][Full Text] [Related]
10. Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey.
Terrier B; Krastinova E; Marie I; Launay D; Lacraz A; Belenotti P; de Saint-Martin L; Quemeneur T; Huart A; Bonnet F; Le Guenno G; Kahn JE; Hinschberger O; Rullier P; Diot E; Lazaro E; Bridoux F; Zénone T; Carrat F; Hermine O; Léger JM; Mariette X; Senet P; Plaisier E; Cacoub P
Blood; 2012 Jun; 119(25):5996-6004. PubMed ID: 22474249
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of cryoglobulinemia and cryoglobulinemic vasculitis in chronically HCV-infected Brazilian patients.
Aguiar MF; Faria-Janes AL; Garcia-Brandes GI; Takemi-Emori C; Ferraz MLG; Andrade LEC; de Souza AWS
Ann Hepatol; 2019; 18(5):685-692. PubMed ID: 31167733
[TBL] [Abstract][Full Text] [Related]
12. Non-infectious cryoglobulinemia vasculitis (CryoVas): update on clinical and therapeutic approach.
Perez-Alamino R; Espinoza LR
Curr Rheumatol Rep; 2014 May; 16(5):420. PubMed ID: 24647999
[TBL] [Abstract][Full Text] [Related]
13. Predictors of early relapse in patients with non-infectious mixed cryoglobulinemia vasculitis: results from the French nationwide CryoVas survey.
Terrier B; Marie I; Launay D; Lacraz A; Belenotti P; de Saint-Martin L; Quemeneur T; Huart A; Bonnet F; Le Guenno G; Kahn JE; Hinschberger O; Rullier P; Diot E; Lazaro E; Bridoux F; Zénone T; Carrat F; Hermine O; Léger JM; Mariette X; Senet P; Plaisier E; Cacoub P
Autoimmun Rev; 2014 Jun; 13(6):630-4. PubMed ID: 24418300
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus-associated polyarteritis nodosa.
Saadoun D; Terrier B; Semoun O; Sene D; Maisonobe T; Musset L; Amoura Z; Rigon MR; Cacoub P
Arthritis Care Res (Hoboken); 2011 Mar; 63(3):427-35. PubMed ID: 20981809
[TBL] [Abstract][Full Text] [Related]
15. The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases.
Terrier B; Karras A; Kahn JE; Le Guenno G; Marie I; Benarous L; Lacraz A; Diot E; Hermine O; de Saint-Martin L; Cathébras P; Leblond V; Modiano P; Léger JM; Mariette X; Senet P; Plaisier E; Saadoun D; Cacoub P
Medicine (Baltimore); 2013 Mar; 92(2):61-68. PubMed ID: 23429354
[TBL] [Abstract][Full Text] [Related]
16. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients.
Gayraud M; Guillevin L; le Toumelin P; Cohen P; Lhote F; Casassus P; Jarrousse B;
Arthritis Rheum; 2001 Mar; 44(3):666-75. PubMed ID: 11263782
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry.
Terrier B; Launay D; Kaplanski G; Hot A; Larroche C; Cathébras P; Combe B; de Jaureguiberry JP; Meyer O; Schaeverbeke T; Somogyi A; Tricot L; Zénone T; Ravaud P; Gottenberg JE; Mariette X; Cacoub P
Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1787-95. PubMed ID: 20740617
[TBL] [Abstract][Full Text] [Related]
18. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
19. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
[TBL] [Abstract][Full Text] [Related]
20. Outcome and prognostic factors during the course of primary small-vessel vasculitides.
Pavone L; Grasselli C; Chierici E; Maggiore U; Garini G; Ronda N; Manganelli P; Pesci A; Rioda WT; Tumiati B; Pavesi G; Vaglio A; Buzio C;
J Rheumatol; 2006 Jul; 33(7):1299-306. PubMed ID: 16783858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
